摘要
Aims: Diabetic nephropathy (DN) complicates diabetes Mellitus and intimately relates to intrarenal renin-angiotensin system (RAS) activity. Dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 (SGLT2), has been validated to improve renal outcomes in diabetic patients from clinical research by elusive mechanisms. This study explored the presumption that the eagerness activity of intrarenal RAS in DN generated oxidative stress to promote renal fibrosis, and the process can be interrupted by dapagliflozin. Methods: A streptozotocin-induced DN model was established in male C57BL/6J mice. Mice were treated with dapagliflozin or losartan for 14 weeks. Biochemical data, renal fibrosis, oxidative stress, and RAS were measured Results: DN mice were characterized by overtly low body weight, high levels of blood glucose, and renal injury. Interrupting SGLT2 and RAS significantly improved renal dysfunction and pathological lesions in DN mice. Consistent with these favorable effects, dapagliflozin revoked the local RAS/oxidative stress and the succeeding transforming growth factor beta (TGF beta) signaling. Conclusions: This research clarifies that intrarenal RAS activity triggers renal injury in DN, and dapagliflozin attenuates renal fibrosis by suppressing Angiotensin II/TGF beta signaling. It unravels a novel insight into the role of prevention and treatment of SGLT2 inhibitors to DN.
学科与关键词
- Dapagliflozin alleviates advanced glycation end product induced podocyte injury through AMPK/mTOR mediated autophagy pathwayYang, Lei; Liang, Baozhu; Li, Jingxin; Zhang, Xiaoyan; Chen, Hong; Sun, Jia; Zhang, Zhen*Cellular Signalling, 2022, 90: 110206.被引 22
- An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathyBai, Zhenyu; Xie, Ting; Liu, Tianhao; Chen, Zedong; Yu, Linde; Zhang, Chao; Luo, Jincheng; Chen, Liguo*; Zhao, Xiaoshan*; Xiao, Ya*Frontiers in Endocrinology, 2022, 13: 967822.被引 2
- Dapagliflozin reverses the imbalance of T helper 17 and T regulatory cells by inhibiting SGK1 in a mouse model of diabetic kidney diseaseWang, Dan; Zhang, Zikun; Si, Zekun; Yang, Yanlin; Li, Shuangshuang; Xue, Yaoming*FEBS Open Bio, 2021, 11(5): 1395-1405.被引 14
